IBA is a privately held biotechnology company whose mission is the delivery of customized bioanalytical method development and sample analysis services to its global client base. IBA can enhance the discovery and development of new drug targets through its expertise in biotechnology, proteomics, biomarker development, and multiplexing technology. Our objective is to develop and maintain long-term strategic alliances with the pharmaceutical and biotech industries.
Located in the shoreline town of Branford, CT, IBA is part of one of the largest private biotech discovery labs in Connecticut with over 36,000 square feet of laboratory space, including a Biosafety Level 2 (BSL-2) laboratory.
Our Team
Science Management Team:
Donald Very, Ph.D.
Vice President, Immunology
Bart Haigh
Director, Analytical Services
Business Management Team:
Michael Fare, MBA
Executive Vice President, Chief Operating Officer
Chuck Sloan
Director, Project Development